Immune checkpoint inhibitors at any treatment line in advanced NSCLC: Real-world overall survival in a large Italian cohort. Andreano A, Bergamaschi W, Russo AG. Lung Cancer 2021;159:145-152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andreano A, Bergamaschi W, Russo AG. Immune checkpoint inhibitors at any treatment line in advanced NSCLC: Real-world overall survival in a large Italian cohort. Lung Cancer 2021;159:145-152.
PMID: 34340111